OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
March 19, 2021
A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies
December 18, 2020
How analytics-driven insights can help drugmakers navigate the leap from trial to market—and add clinical and financial value at every step
September 26, 2020
Both COVID-19 vaccine delivery and the growth of cellular/genetic therapies call for lower storage and shipping temperatures
February 17, 2019
As the definition of ‘targeted’ therapies—especially in oncology—and as a component of companion diagnostics, biomarkers are creating opportunities in drug research and commercialization